Cargando…
Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial
BACKGROUND: Intravitreal triamcinolone acetonide (IVTA) is an effective treatment for recalcitrant diabetic macular oedema (DMO). It has been shown to improve vision with benefits persisting up to five years. The most common initial side effect of IVTA treatment is rise in intraocular pressure, occu...
Autores principales: | O’Day, Roderick F, Barthelmes, Daniel, Zhu, Meidong, Wong, Tien Y, McAllister, Ian L, Arnold, Jennifer J, Gillies, Mark C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223852/ https://www.ncbi.nlm.nih.gov/pubmed/25335434 http://dx.doi.org/10.1186/1471-2415-14-123 |
Ejemplares similares
-
Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O’Day, Roderick, et al.
Publicado: (2013) -
Intravitreal triamcinolone acetonide: Pattern of secondary intraocular pressure rise and possible risk factors
por: Bashshur, Ziad F, et al.
Publicado: (2008) -
Intraocular Pressure Following Intravitreal Injection of Triamcinolone Acetonide
por: Ansari, Ejaz A, et al.
Publicado: (2008) -
Comparison of the intraocular pressure following an intravitreal triamcinolone acetonide injection for diabetic macula oedema in vitrectomised and non-vitrectomised eyes
por: Orii, Yusuke, et al.
Publicado: (2021) -
Delivery of Intraocular Triamcinolone Acetonide in the Treatment of Macular Edema
por: Pickrell, Aaron, et al.
Publicado: (2012)